Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products
Top Cited Papers
- 7 March 2010
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 28 (3) , 281-288
- https://doi.org/10.1038/nbt.1611
Abstract
Effective proteome-wide strategies that distinguish the N-termini of proteins from the N-termini of their protease cleavage products would accelerate identification of the substrates of proteases with broad or unknown specificity. Our approach, named terminal amine isotopic labeling of substrates (TAILS), addresses this challenge by using dendritic polyglycerol aldehyde polymers that remove tryptic and C-terminal peptides. We analyze unbound naturally acetylated, cyclized or labeled N-termini from proteins and their protease cleavage products by tandem mass spectrometry, and use peptide isotope quantification to discriminate between the substrates of the protease of interest and the products of background proteolysis. We identify 731 acetylated and 132 cyclized N-termini, and 288 matrix metalloproteinase (MMP)-2 cleavage sites in mouse fibroblast secretomes. We further demonstrate the potential of our strategy to link proteases with defined biological pathways in complex samples by analyzing mouse inflammatory bronchoalveolar fluid and showing that expression of the poorly defined breast cancer protease MMP-11 in MCF-7 human breast cancer cells cleaves both endoplasmin and the immunomodulator and apoptosis inducer galectin-1.Keywords
This publication has 49 references indexed in Scilit:
- Enzymatic route to preparative-scale synthesis of UDP–GlcNAc/GalNAc, their analogues and GDP–fucoseNature Protocols, 2010
- False Discovery Rates of Protein Identifications: A Strike against the Two-Peptide RuleJournal of Proteome Research, 2009
- Comparative Assessment of Large-Scale Proteomic Studies of Apoptotic ProteolysisACS Chemical Biology, 2009
- Global Sequencing of Proteolytic Cleavage Sites in Apoptosis by Specific Labeling of Protein N TerminiCell, 2008
- Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein SheddingMolecular and Cellular Biology, 2008
- Global Mapping of the Topography and Magnitude of Proteolytic Events in ApoptosisCell, 2008
- Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Complexes by MMP-2 ProteolysisMolecular and Cellular Biology, 2007
- Profiling constitutive proteolytic events in vivoBiochemical Journal, 2007
- LPS Responsiveness and Neutrophil Chemotaxis In Vivo Require PMN MMP-8 ActivityPLOS ONE, 2007
- A uniform proteomics MS/MS analysis platform utilizing open XML file formatsMolecular Systems Biology, 2005